China Bans All Poultry Imports From Brazil on Bird Flu Case
China has banned imports of all poultry products from Brazil after a bird flu outbreak was detected in the world's top exporter, halting a trade worth more than $1 billion.
Direct and indirect imports of all poultry and related products from Brazil are banned in order to prevent the importation of bird flu, China's customs agency said in a statement published late Friday. The agency also said all plants and animal waste arriving from Brazil must undergo disinfestation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
16 minutes ago
- Fox News
Real Madrid confirms Xabi Alonso is returning as 'one of the best coaches in the world'
Xabi Alonso is returning to Real Madrid to take over a club that failed to meet expectations this season. The Spanish powerhouse announced the hiring of Alonso on Sunday to replace Carlo Ancelotti, who is leaving to take over the Brazil job. Alonso will take over on June 1 and will be given a contract through June 2028, the club said. He's to be presented as coach on Monday. The 65-year-old Ancelotti is departing after four mostly successful seasons with Madrid. He bid a tearful farewell on Saturday in the team's final Spanish league match. Ancelotti's contract ran to the end of next season, but the club confirmed his departure on Friday after he had already been announced as the next Brazil coach. Madrid began the season by winning the UEFA Super Cup title but mostly struggled since then, failing to lift another trophy and losing all four "clásico" matches against rival Barcelona, which clinched a league and cup double. Ancelotti on Friday said he felt Alonso had the potential to succeed at Madrid. "I don't want to offer advice, because everyone has their own ideas about soccer," he said. "All I can say is that he's hugely fortunate to be Real Madrid's coach. I wish him all the best, and all the luck in the world. I think he has the attributes to coach this team. I hope he enjoys it." The club's official TV channel prepared a video with highlights of Alonso's career, both as a player and as a coach, saying that "now he has in front of him the greatest challenge any coach can face, which is to sit on the bench of Real Madrid." The 43-year-old Alonso is returning to a familiar environment. "Alonso is one of the biggest legends of Real Madrid and world football. He defended our shirt in 236 official games between 2009 and 2014. He won six titles during this time: the 10th European Cup in Lisbon, one European Super Cup, one league title, two Spanish Cups and one Spanish Super Cup," the club said. "Now he's returning to Real Madrid as one of the best coaches in the world after making history with Bayer Leverkusen," the club said. As coach, Alonso led Leverkusen to an unprecedented German league and cup double last year in his first full season after taking over the team when it was in the Bundesliga's relegation zone the season before. His team remains the only one to complete a whole Bundesliga campaign unbeaten. Leverkusen's only defeat in 2023-24 was to Atalanta in the Europa League final, and it bounced back three days later by winning the 2024 German Cup. Leverkusen's 35-game unbeaten run in the Bundesliga ended in August 2024 with a 3-2 loss at home to Leipzig, against whom Alonso's team uncharacteristically squandered a two-goal lead. "You didn't just train us — you inspired us," Leverkusen captain Granit Xhaka wrote on Instagram after Alonso confirmed his departure. "We'll carry your lessons far beyond the field." As a player for Spain and Madrid, Alonso displayed an understanding of the game and technical skills that created time and space for himself, and opportunities for others. Real Sociedad and Liverpool previously benefited from his intelligence in midfield. He helped the latter to the Champions League title in 2005. Alonso starred as a Madrid player, winning six titles, including the Spanish league in 2012 and the 2014 Champions League before leaving for three Bundesliga titles with Bayern Munich. There was always a feeling in Madrid he would return. The club takes pride in bringing former greats back for coaching or management roles, like Zinedine Zidane or Jorge Valdano, and Alonso seemed predestined for coaching after a playing career spent managing teammates. Alonso began his coaching career with Madrid's youth teams before returning to Real Sociedad, another former club, to take over its reserve team. He led it to promotion. He exceeded expectations after Leverkusen sporting director Simon Rolfes and chief executive Fernando Carro gave him his first job in senior management in October 2022. Now he will face different demands at Madrid, where he will be tasked with responding to a buoyant Barcelona team spearheaded by the outstanding Lamine Yamal and Brazil forward Raphinha supported by a cast of home-grown young stars such as Pedri and Gavi. He will have to put the team's top stars – Kylian Mbappe, Jude Bellingham and Vinicius Junior – back on track after they failed to help the team succeed toward the end of the season. Despite his success in leading Madrid to three Champions League titles, Ancelotti was considered a coach who largely let the players have their way, giving their individual brilliance full reign. Alonso is likely to be more structured with a clear idea of how he wants each player to fit into his team. One priority will be strengthening the defense after serious injuries there last season undermined Ancelotti's hopes of defending the Spanish league and Champions League titles. Madrid has already addressed that with the signing of Spain defender Dean Huijsen from Bournemouth. More arrivals are likely. Whichever players come or go, Alonso will face the same demands — to get Madrid back on top in Spain and challenging for a record-extending 16th European crown. It's just his second job in senior management. Reporting by The Associated Press.
CBS News
21 minutes ago
- CBS News
Transcript: FDA commissioner Dr. Marty Makary on "Face the Nation with Margaret Brennan," June 1, 2025
The following is the transcript of an interview with FDA commissioner Dr. Marty Makary that aired on "Face the Nation with Margaret Brennan" on June 1, 2025. MARGARET BRENNAN: Welcome back to Face the Nation. We're joined now by FDA Commissioner Dr. Marty Makary. Good morning. FDA COMMISSIONER DR. MARTY MAKARY: Good morning. MARGARET BRENNAN: Good to have you here in person. DR. MAKARY: Good to be here. MARGARET BRENNAN: So I want to get through a lot here, but one of the things we've noticed is this new COVID variant that seems to be circulating in Asia. I believe it's NB.1.8.1. It's a variant under monitoring. What do we need to know? DR. MAKARY: Yeah so this appears to be a subvariant of JN.1, which has been the dominant strain so it's believed that there is cross-immunity protection. The COVID- COVID virus is going to continue to mutate, and it's behaving like a common cold virus. It's now going to become the fifth coronavirus that's seasonal, that causes about 25% of the cases of the common cold. MARGARET BRENNAN: So you're thinking of it as like a flu-type variant, just a normal fluctuation. DR. MAKARY: The flu mutates about 34 times more frequently than COVID. The COVID variant mutation rate appears to be a little more stable, but the international bodies that have provided some guidance on which strain to target, have suggested that either JN.1 or any of these subvariants would be reasonable strains to target. MARGARET BRENNAN: So you don't seem overly concerned about that. I want to get now into some of the recommendations that have been very specific this week from the CDC and you with the HHS Secretary in this video announcement on Tuesday where Secretary Kennedy said the CDC was removing the COVID vaccine for healthy children and healthy pregnant women from its recommended immunization schedule. He then had a memo to the CDC rescinding recommendations for kids' vaccines, saying the known risks do not outweigh the benefits. Then late Thursday, the CDC said quote "shared clinical decision-making," which I think is just talking to your doctor should determine whether kids get vaccinated. Can you clearly state what the policy is? Because this is confusing. DR. MAKARY: Yeah, we believe the recommendation should be with a patient and their doctor. So we're going to get away from these blanket recommendations in healthy, young Americans because we don't want to see-- MARGARET BRENNAN: For all vaccines? DR. MAKARY: We don't- well on the COVID vaccine schedule, we don't want to see kids kicked out of school because a 12-year-old girl is not getting her fifth COVID booster shot. We don't see the data there to support a young, healthy child getting a repeat, infinite, annual COVID vaccine. There's a theory that we should sort of blindly approve the new COVID boosters in young, healthy kids every year in perpetuity, and a young girl born today should get 80 COVID mRNA shots, or other COVID shots in her average lifespan. We're saying that's a theory, and we'd like to check in and get some randomized, controlled data. It's been about four years since the original randomized trials, so we'd like an evidence based approach. Dr. Prasad and I published this in the New England Journal of Medicine last week, and we're basically saying we'd like to bring some confidence back to the public around this repeat booster strategy theory, because-- MARGARET BRENNAN: Your statement was not about repeat boosters. It says the vaccine is not recommended for pregnant women, the vaccine is not recommended for healthy children. That's different than annual boosters. DR. MAKARY: Yeah at this point we're dealing, you know, it is a booster strategy- people would be getting the updated shot. So whether or not a young, healthy-- (CROSSTALK) MARGARET BRENNAN: But what about kids who haven't gotten a shot? DR. MAKARY: So we'd like to see the data. We'd love to see that- that data. It doesn't exist. MARGARET BRENNAN: No, no, no, but on a practical level, for a parent at home, hearing you, trying to make sense here. DR. MAKARY: Yeah. We're saying, take it back to your doctor. MARGARET BRENNAN: Their child has not been vaccinated. Are you recommending that their first encounter with COVID be an actual infection? (END CROSSTALK) DR. MAKARY: We're not going to push the COVID shot in young, healthy kids without any clinical trial data supporting it. That is a decision between a parent and their doctor. And just so, I don't know if you know the statistics, but 80 for 88% of American kids, their parents, have said no to the COVID shot last season. So America, the vast majority Americans, are saying no. Maybe they want to see some clinical data as well. Maybe they have concerns about the safety-- (CROSSTALK) MARGARET BRENNAN: I don't want to crowdsource my health guidance. I want a clear thing-- DR. MAKARY: The worst thing you-- MARGARET BRENNAN: --I wouldn't go with popularity-- DR. MAKARY: The worst thing-- MARGARET BRENNAN: --I'm going with, as you're saying, data-- DR. MAKARY: --Yeah so let's see the data. (END CROSSTALK) MARGARET BRENNAN: Okay. So the CDC data said 41% of children aged six months to 17 years hospitalized with COVID between 2022 and 2024 did not have a known underlying condition. In other words, they looked healthy-- DR. MAKARY: So-- MARGARET BRENNAN: --and COVID was serious for them. DR. MAKARY: So first of all, we know the CDC data is contaminated with a lot of false positives from incidental positive COVID tests with routine testing of every kid that walks in the hospital-- MARGARET BRENNAN: You don't trust the CDC data? DR. MAKARY: --When I go to the ICU, when I walk to the P- the we know, We know that data, historically under the Biden administration, did not distinguish being sick from COVID or an incidental positive COVID test. When you go to an ICU in America and you ask, how many people are in the ICU that are healthy, that are sick with COVID, the answer I get again and again is, we haven't seen that in a year or years. And so the worst thing you can do in public health is to put out an absolute universal recommendation in young, healthy kids. And the vast majority of Americans are saying, no, we want to see some data. And you say, Forget about the data. Just get it anyway. MARGARET BRENNAN: Okay, so on data and transparency for decades, since 1964 it was the Advisory Committee on Immunization Practices, ACIP that went through this panel recommendation. People watched these things during COVID. The report was then handed up. It offered debate, it offered transparency, and it offered data points that people could refer back to. Why did you bypass all of this and just come down with a decision before the panel could meet and meet that data? DR. MAKARY: That panel has been a kangaroo court where they just rubber stamp every single vaccine put in front of them. If you look at the minutes of the report from, they even say we were- generally want to move towards a risk stratified approach. MARGARET BRENNAN: So why not let them do that in June? DR. MAKARY: So in the meantime, we don't want an absolute recommendation for healthy kids to get it. They can do it, and that committee-committee will meet and make recommendations. But you look at the minutes of the last couple of years, they say we want a simple message for everybody, just so they can understand it. It was not a data based conversation. It was a conversation based on marketing and ease and and I've written an article titled "Why the people don't trust the CDC," and it's in part from that blanket strategy– MARGARET BRENNAN: You're telling them not to right now. You just said don't trust the CDC. DR. MAKARY: We're saying it's going to be between a doctor and a patient until that committee meets or more experts weigh in, or we get some clinical data. If there's zero clinical data, you're opining. I mean, you're just, it's a theory, and so we don't want to put out an absolute recommendation for kids with no clinical data at this point. MARGARET BRENNAN: So you made this pronouncement as well on pregnant women. There is data. Researchers in the UK analyzed a series of 67 studies, which included 1.8 million women, and the journal BMJ Global Health published it. People can Google it at home, and it says the COVID vaccine in pregnant women is highly effective in reducing the odds of maternal SARS-CoV-2 infection, hospital admission and improves pregnancy outcomes with no serious safety concerns. This is data that shows that it is recommended or could be advised, for pregnant women to take this vaccine. Why do you find otherwise? DR. MAKARY: There's no randomized control trial. That's the gold standard. Those 67 studies are mixed. The data in pregnant women is different for healthy versus women with a comorbid condition. So it's a very mixed bag. So we're saying your obstetrician, your primary care doctor, and the pregnant woman should together decide whether or not to get it. 12% of pregnant women last year got the COVID shot. So people have serious concerns, and it's probably because they want to see a randomized trial data, the randomized trial of pregnant women– MARGARET BRENNAN: But in the meantime, the world moves on, and you published in the New England Journal of Medicine on May 20. In that report, you referenced, you listed pregnancy as an underlying medical condition that increases a person's risk for severe COVID. You said that. So then seven days later, you joined in this video announcement saying you should drop the recommendation for the COVID vaccine in healthy pregnant women. So what changed in the seven days? DR. MAKARY: In the New England Journal medicine, we simply list what the f- what the CDC has traditionally defined as high risk, and we're just saying, decide with your doctor. We're not saying the other– MARGARET BRENNAN: But doctors want data and information as well from you– DR. MAKARY: and the randomized trial– so here's the data on pregnant women. A randomized control trial was set up, and it was closed without any explanation. We wanted to see that trial complete so women can have information that in a randomized control trial, which is the gold standard, this is what the data shows. We don't have those data. MARGARET BRENNAN: All right. It is still unclear what pregnant women now should do until they get the data that you say-- DR. MAKARY: I'd say talk to their doctor. MARGARET BRENNAN: When do they get the data you're promising? All these controlled studies. DR. MAKARY: In the absence of data, they should talk to their doctor-- MARGARET BRENNAN: So no date? DR. MAKARY: --and their doctor will use their best wisdom and judgment. MARGARET BRENNAN: FDA Commissioner, thank you for trying to help clear this up.
Yahoo
25 minutes ago
- Yahoo
US Defense Secretary Hegseth signals Asia commitment with China warnings
US Defense Secretary Pete Hegseth warned that China poses an 'imminent' threat to Taiwan and called on Asian allies to boost defense spending, in a speech that won plaudits from other regional officials. Washington's partners had reason to be wary of Hegseth's remarks at the Shangri-La Dialogue defense conference: Vice President JD Vance used a similar gathering in Munich this year to flame European allies. But Hegseth's criticism of China — which Beijing rebuked as divisive — was 'a clear statement of commitment to the region,' an expert told The Japan Times. While his speech may not have burned diplomatic bridges, it hasn't allayed Asian allies' economic anxiety over US President Donald Trump's erratic tariff policy, Bloomberg wrote.
